Literature DB >> 25541749

DOCKTITE-a highly versatile step-by-step workflow for covalent docking and virtual screening in the molecular operating environment.

Christoph Scholz1, Sabine Knorr, Kay Hamacher, Boris Schmidt.   

Abstract

The formation of a covalent bond with the target is essential for a number of successful drugs, yet tools for covalent docking without significant restrictions regarding warhead or receptor classes are rare and limited in use. In this work we present DOCKTITE, a highly versatile workflow for covalent docking in the Molecular Operating Environment (MOE) combining automated warhead screening, nucleophilic side chain attachment, pharmacophore-based docking, and a novel consensus scoring approach. The comprehensive validation study includes pose predictions of 35 protein/ligand complexes which resulted in a mean RMSD of 1.74 Å and a prediction rate of 71.4% with an RMSD below 2 Å, a virtual screening with an area under the curve (AUC) for the receiver operating characteristics (ROC) of 0.81, and a significant correlation between predicted and experimental binding affinities (ρ = 0.806, R(2) = 0.649, p < 0.005).

Mesh:

Substances:

Year:  2015        PMID: 25541749     DOI: 10.1021/ci500681r

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  24 in total

Review 1.  Docking Screens for Novel Ligands Conferring New Biology.

Authors:  John J Irwin; Brian K Shoichet
Journal:  J Med Chem       Date:  2016-03-15       Impact factor: 7.446

2.  Covalent docking using autodock: Two-point attractor and flexible side chain methods.

Authors:  Giulia Bianco; Stefano Forli; David S Goodsell; Arthur J Olson
Journal:  Protein Sci       Date:  2015-07-07       Impact factor: 6.725

3.  Covalent Antiviral Agents.

Authors:  Sako Mirzaie; Fatemeh Abdi; Amin GhavamiNejad; Brian Lu; Xiao Yu Wu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Discovery of Lysine-Targeted eIF4E Inhibitors through Covalent Docking.

Authors:  Xiaobo Wan; Tangpo Yang; Adolfo Cuesta; Xiaming Pang; Trent E Balius; John J Irwin; Brian K Shoichet; Jack Taunton
Journal:  J Am Chem Soc       Date:  2020-03-04       Impact factor: 15.419

Review 5.  Road Map for the Structure-Based Design of Selective Covalent HCV NS3/4A Protease Inhibitors.

Authors:  Letitia Shunmugam; Pritika Ramharack; Mahmoud E S Soliman
Journal:  Protein J       Date:  2017-10       Impact factor: 2.371

6.  Dipeptidyl Nitroalkenes as Potent Reversible Inhibitors of Cysteine Proteases Rhodesain and Cruzain.

Authors:  Antonio Latorre; Tanja Schirmeister; Jochen Kesselring; Sascha Jung; Patrick Johé; Ute A Hellmich; Anna Heilos; Bernd Engels; R Luise Krauth-Siegel; Natalie Dirdjaja; Lledó Bou-Iserte; Santiago Rodríguez; Florenci V González
Journal:  ACS Med Chem Lett       Date:  2016-09-21       Impact factor: 4.345

Review 7.  Building a virtual ligand screening pipeline using free software: a survey.

Authors:  Enrico Glaab
Journal:  Brief Bioinform       Date:  2015-06-20       Impact factor: 11.622

8.  Development of a Potent Inhibitor of the Plasmodium Proteasome with Reduced Mammalian Toxicity.

Authors:  Gregory M LaMonte; Jehad Almaliti; Betsaida Bibo-Verdugo; Lena Keller; Bing Yu Zou; Jennifer Yang; Yevgeniya Antonova-Koch; Pamela Orjuela-Sanchez; Colleen A Boyle; Edgar Vigil; Lawrence Wang; Gregory M Goldgof; Lena Gerwick; Anthony J O'Donoghue; Elizabeth A Winzeler; William H Gerwick; Sabine Ottilie
Journal:  J Med Chem       Date:  2017-07-25       Impact factor: 7.446

9.  Inhibition of homologous phosphorolytic ribonucleases by citrate may represent an evolutionarily conserved communicative link between RNA degradation and central metabolism.

Authors:  Carlanne M Stone; Louise E Butt; Joshua C Bufton; Daniel C Lourenco; Darren M Gowers; Andrew R Pickford; Paul A Cox; Helen A Vincent; Anastasia J Callaghan
Journal:  Nucleic Acids Res       Date:  2017-05-05       Impact factor: 16.971

10.  Identification and analysis of novel small molecule inhibitors of RNase E: Implications for antibacterial targeting and regulation of RNase E.

Authors:  Charlotte E Mardle; Layla R Goddard; Bailei C Spelman; Helen S Atkins; Louise E Butt; Paul A Cox; Darren M Gowers; Helen A Vincent; Anastasia J Callaghan
Journal:  Biochem Biophys Rep       Date:  2020-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.